Accu-Break Pharmaceuticals
Fort Lauderdale · Founded 2001
About Accu-Break Pharmaceuticals
ACCU-BREAK Pharmaceuticals, Inc. develops and licenses pharmaceutical tablet technologies. The company offers bi-layer and tri-layer technologies, which are used to create tablets that are dividable by hand into accurate partial/smaller doses for patients to adjust their dose. Its technologies are used for single drug products, fixed and split combination drug products, standard and controlled release formulations, and incompatible drugs in human and veterinary medicines. The company has a strategic alliance agreement with Azopharma Development Group. ACCU-BREAK Pharmaceuticals, Inc. was formerly known as SoLapharm, Inc. and changed its name to ACCU-BREAK Pharmaceuticals, Inc.
Company Facts
- Founded: 2001
- Legal name: Accu-Break Pharmaceuticals, Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.7M
- Funding stage: Seed
- Last round: Seed (May 2013)
- Website: accubreakpharmaceuticals.com
- Phone: +1 9542367271
Social Profiles
Canonical: https://fsome.com/organization/accu-break-pharmaceuticals-8395944 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.